ADVM – adverum biotechnologies, inc. (US:NASDAQ)
Stock Stats
News
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $25.00 price target on the stock.
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors [Yahoo! Finance]
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Form 4 Adverum Biotechnologies, For: Jun 17 Filed by: Nicholson, C. David
Form 4 Adverum Biotechnologies, For: Jun 17 Filed by: Ozden Rabia Gurses
Form 4 Adverum Biotechnologies, For: Jun 17 Filed by: Hong Soo
Form 4 Adverum Biotechnologies, For: Jun 17 Filed by: Lupher, Jr. Mark L.
Form 4 Adverum Biotechnologies, For: Jun 17 Filed by: Svoronos Dawn
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.